angiotensin ii has been researched along with l 158809 in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 37 (50.00) | 18.2507 |
2000's | 37 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anzini, M; Cappelli, A; De Benedetti, PG; Ferrari, F; Gallelli, A; Giorgi, G; Makovec, F; Mennuni, L; Menziani, MC; Pericot Mohr Gl, Gl; Rizzo, M; Vomero, S | 1 |
Anzini, M; Cappelli, A; Caselli, G; Ferrari, F; Gallelli, A; Giordani, A; Giorgi, G; Giuliani, G; Makovec, F; Mennuni, L; Mohr, Gl; Nannicini, C; Peris, W; Valenti, S; Vomero, S | 1 |
Gessner, GW; Jarvis, MF; Ly, CQ | 1 |
Chakravarty, PK; Chang, RS; Clineschmidt, BV; Greenlee, WJ; Lotti, VJ; Mantlo, NB; Patchett, AA; Siegl, PK | 1 |
Chakravarty, PK; Chang, RS; Greenlee, WJ; Lotti, VJ; Mantlo, NB; Ondeyka, DL; Patchett, AA; Siegl, PK; Sweet, CS | 1 |
Caussade, F; Cazes, M; Cloarec, A; Delchambre, C; Versigny, A; Virone-Oddos, A | 1 |
Mitchell, KD; Mullins, JJ | 1 |
Greenlee, WJ; Hjorth, SA; Perlman, S; Rivero, RA; Schambye, HT; Schwartz, TW | 1 |
Adams, K; Greenlee, WJ; Nachbar, RB; Patchett, AA; Prendergast, K; Underwood, DJ | 1 |
Cheng, DY; DeWitt, BJ; Kadowitz, PJ; McMahon, TJ | 1 |
Grove, KL; Speth, RC | 1 |
Bagley, SW; Chakravarty, PK; Chang, RS; Chen, TB; Dhanoa, DS; Kivlighn, SD; Lotti, VJ; Patchett, AA; Siegl, PK; Zingaro, GJ | 1 |
Dagenais, P; Escher, E | 1 |
Bossé, R; Boulay, G; Escher, E; Guillemette, G; Servant, G; Zhou, LM | 1 |
Cazes, M; Cloarec, A; Provost, D; Versigny, A | 1 |
Acker, WR; Chang, RS; Drag, MD; Fujita, T; Greenlee, WJ; Holder, DJ; Huckle, WR; Johnson, RG; Kim, D; Mantlo, NB; McFall, RC; Ondeyka, DL; Powers, M; Reilly, CF; Schwartz, RS; Stabilito, II | 1 |
Almansa, C; Carceller, E; Cavalcanti, FL; de Arriba, AF; Forn, J; García-Rafanell, J; Gómez, LA; Rodríguez, R | 1 |
Barber, L; Dalen, H; Davies, MG; Fulton, GJ; Hagen, PO; Svendsen, E | 1 |
Harada, K; Ogura, T; Oishi, T; Ota, Z; Yamauchi, T | 1 |
Maeda, K; Matsumura, Y; Morimoto, S; Nishiura, M; Nonaka, H; Urabe, K | 1 |
Bourgeois, R; Escher, E; Laporte, S; Pérodin, J; Pham, D | 1 |
Fogo, A; Freeman, M; Lo, W; Oikawa, T; Vaughan, DE | 1 |
Bertani, T; Colosio, V; Corna, D; Donadelli, R; Facchinetti, D; Luzzana, E; Maffi, R; Remuzzi, G; Testa, D; Zoja, C | 1 |
Liu, JL; Murakami, H; Zucker, IH | 1 |
Charlier, AA; Donckier, J; Hayashida, W; Pouleur, H; Van Mechelen, H | 2 |
Costa-Neto, CM; Greenlee, WJ; Hjorth, SA; Miyakawa, AA; Paiva, AC; Perlman, S; Rivero, RA; Schambye, HT; Schwartz, TW | 1 |
Escher, E; Hildgen, P; Lacasse, FX; McMullen, JN; Pérodin, J; Phillips, NC | 1 |
Christy, DH; Davison, G; Hall, CS; Lanza, GM; Miller, JG; Scott, MJ; Wickline, SA | 1 |
Gillies, LK; Lee, RM; Lu, M; Wang, H | 1 |
Barber, L; Davies, MG; Fulton, GJ; Hagen, PO; Svendsen, E | 1 |
Ford, WR; Jugdutt, BI; Khan, MI | 1 |
Cox, BE; Kaiser, JR; Rosenfeld, CR; Roy, TA | 1 |
Asano, N; Kataoka, H; Kishida, M; Makino, H; Mimura, Y; Ogura, T; Otsuka, F; Yamauchi, T | 1 |
Clark, JT; Keaton, AK | 1 |
Greenland, BD; Grossman, W; Lynch, JJ; Shen, YT; Wiedmann, RT | 1 |
Kageyama, J; Makino, H; Ogura, T; Otsuka, F; Takahashi, M; Yamauchi, T | 1 |
Jung, YS; Lee, BH; Lee, SH; Shin, HS; Yoo, SE; Yun, SI | 1 |
Cohen, EP; Datta, PK; Fish, BL; Lianos, EA; Moulder, JE | 2 |
Clark, KE; Greenberg, SG; Lambers, DS | 1 |
Gerdes, AM; Harris, J; Lu, W; Said, S; Tamura, T | 1 |
Bulagannawar, M; Carretero, OA; Cavasin, MA; Karumanchi, R; Liu, YH; Mehta, D; Yang, XP | 1 |
Donnelly, R; Gray, S; Idris, I; Patiag, D; Qu, X; Seale, JP; Wilkes, M | 1 |
Asada, K; Jin, D; Kondo, K; Matsuyama, N; Miyazaki, M; Nishimoto, M; Sasaki, S; Sawada, Y; Takai, S; Yuda, A | 1 |
Levitan, ES; Stewart, AF; Takimoto, K; Zhang, TT; Zhu, C | 1 |
Clark, MA; Diz, DI; Tallant, EA | 1 |
Benigni, A; Gagliardini, E; Grunkemeyer, JA; Kalluri, R; Remuzzi, G; Tomasoni, S; Zoja, C | 1 |
Beshara, G; Ghali, R; Sabra, R; Serhal, H; Sharaf, LH; Zeinoun, N | 1 |
Chayama, K; Fujimoto, Y; Sasaki, T; Tsuchida, A | 1 |
Bechtold, AG; Scheuer, DA | 1 |
Ishida, M; Kambe, M; Kurisu, S; Masaki, H; Matsubara, H; Matsuura, H; Oshima, T; Ozono, R; Sugino, H; Teranishi, Y | 1 |
Maki, T; Nasa, Y; Takahashi, M; Takeo, S; Tanonaka, K; Yoshida, H | 1 |
Andersen, SM; Gerdes, AM; McCune, SA; Mochizuki, S; Said, S; Tamura, T | 1 |
Li, X; Papp, M; Uhal, BD; Wang, R; Zhuang, J | 1 |
Carretero, OA; Garvin, JL; Ren, Y | 1 |
Miettinen, A; Tikkanen, I; Uhlenius, N; Vuolteenaho, O | 1 |
Naito, Y; Takada, A; Takada, Y; Urano, T; Yoshida, M | 1 |
Hashimoto, K; Satoh, Y; Sugiyama, A; Yoneyama, M; Yoshida, H | 1 |
Hobara, N; Inaizumi, K; Kawasaki, H; Kurosaki, Y; Nakamura, A | 1 |
Chung, CH; Hong, SY; Kim, MJ; Lee, EY; Shim, MS; Shin, YG | 1 |
Adler, SG; Cheon Park, H; Ha, SK; Han, DS; Kang, SW; Natarajan, R; Ryu, DR; Xu, ZG; Yoo, TH | 1 |
Avedanian, L; Bkaily, G; D'Orleans-Juste, P; El-Bizri, N; Gobeil, F; Hazzouri, KM; Jacques, D; Nader, M; Regoli, D; Riopel, J | 1 |
Hyjek, E; Jaggi, JS; McDevitt, MR; Scheinberg, DA; Seshan, SV; Sgouros, G | 1 |
Gao, L; Li, YF; Li, YL; Liu, D; Patel, KP; Schultz, HD; Wang, W; Xia, XH; Zheng, H | 1 |
Li, YL; Schultz, HD | 1 |
Castells, MT; Loria, A; Reverte, V; Saez, F; Salazar, F; Salazar, FJ; Zuasti, A | 1 |
Diz, DI; Gilliam-Davis, S; Kasper, SO; Payne, VS; Robbins, ME; Tommasi, EN | 1 |
Cohen, EP; Fish, BL; Li, XA; Moulder, JE; Sharma, M | 1 |
Bian, YL; Jiang, ZL; Long, DK; Qi, YX; Shen, BR; Yan, ZQ | 1 |
Brooks, RM; Faraci, FM; Heistad, DD; Lund, DD | 1 |
Anan, A; Irie, M; Iwata, K; Sakisaka, S; Shakado, S; Sohda, T; Takeyama, Y | 1 |
MacLeod, KM; McNeill, JH; Tran, LT | 1 |
Hasser, EM; Heesch, CM; Kvochina, L | 1 |
1 review(s) available for angiotensin ii and l 158809
Article | Year |
---|---|
Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Imidazoles; Microscopy, Electron; Microscopy, Electron, Scanning; Rabbits; Tetrazoles; Tunica Intima; Tunica Media; Vasoconstriction; Vasoconstrictor Agents; Veins | 1998 |
73 other study(ies) available for angiotensin ii and l 158809
Article | Year |
---|---|
Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Binding, Competitive; Computer Simulation; Crystallography, X-Ray; Drug Design; Imidazoles; In Vitro Techniques; Isometric Contraction; Ligands; Liver; Male; Models, Molecular; Molecular Structure; Muscle, Smooth, Vascular; Purines; Pyridines; Quinolines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Structure-Activity Relationship; Tetrazoles | 2004 |
Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Bridged Bicyclo Compounds, Heterocyclic; Caco-2 Cells; Cell Membrane Permeability; Crystallography, X-Ray; Drug Design; Humans; Intestinal Mucosa; Male; Models, Molecular; Molecular Structure; Pyrazoles; Pyridines; Rabbits; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Stereoisomerism; Structure-Activity Relationship | 2008 |
The angiotensin hexapeptide 3-8 fragment potently inhibits [125I]angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortex.
Topics: Adrenal Cortex; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Binding Sites; Binding, Competitive; Cattle; Dioxanes; Imidazoles; Radioligand Assay; Receptors, Angiotensin; Tetrazoles | 1992 |
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Biphenyl Compounds; Brain; Cell Membrane; Culture Techniques; Humans; Imidazoles; Losartan; Macaca mulatta; Muscle, Smooth, Vascular; Rabbits; Rats; Species Specificity; Tetrazoles | 1992 |
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Imidazoles; Injections, Intravenous; Losartan; Macaca mulatta; Male; Pressoreceptors; Pyridines; Rats; Rats, Inbred Strains; Tetrazoles | 1992 |
In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Binding, Competitive; Biphenyl Compounds; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Losartan; Male; Muscle, Smooth, Vascular; Pyrimidines; Radioligand Assay; Rats; Tetrazoles | 1995 |
ANG II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Blood Pressure; Feedback; Glomerular Filtration Rate; Hemodynamics; Hydrostatic Pressure; Hypertension; Imidazoles; Kidney Glomerulus; Kidney Tubules; Male; Rats; Renal Circulation; Tetrazoles | 1995 |
Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Animals; Binding, Competitive; Biphenyl Compounds; Cell Line; Chlorocebus aethiops; CHO Cells; Cricetinae; Humans; Imidazoles; Inositol Phosphates; Kidney; Kinetics; Ligands; Molecular Sequence Data; Mutagenesis, Insertional; Phosphatidylinositols; Point Mutation; Polymerase Chain Reaction; Protein Structure, Secondary; Rats; Receptors, Angiotensin; Recombinant Proteins; Tetrazoles; Transfection; Xenopus laevis | 1995 |
Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Binding Sites; Computer-Aided Design; Drug Design; Electrochemistry; Imidazoles; Models, Molecular; Molecular Conformation; Molecular Structure; Receptors, Angiotensin; Structure-Activity Relationship; Tetrazoles; Thermodynamics | 1994 |
Comparison of pressor responses to angiotensin I, II, and III in pulmonary vascular bed of cats.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Captopril; Cats; Female; Imidazoles; Male; Pulmonary Circulation; Tetrazoles | 1994 |
Angiotensin II and non-angiotensin II displaceable binding sites for [3H]losartan in the rat liver.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Binding, Competitive; Biphenyl Compounds; Imidazoles; Liver; Losartan; Male; Rats; Receptors, Angiotensin; Subcellular Fractions; Tetrazoles; Tritium | 1993 |
(Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Brain; Imidazoles; Losartan; Phenylacetates; Rabbits; Rats; Receptors, Angiotensin; Tetrazoles | 1993 |
Anti-angiotensin antibodies cross-reactive with nonpeptide angiotensin antagonists as angiotensin receptor model.
Topics: Adrenocorticotropic Hormone; Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies; Biphenyl Compounds; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Imidazoles; Losartan; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Naloxone; Pyridines; Saralasin; Structure-Activity Relationship; Tetrazoles | 1993 |
Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor.
Topics: Adrenal Cortex; Affinity Labels; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Binding, Competitive; Cattle; Cells, Cultured; Female; Humans; Imidazoles; In Vitro Techniques; Myometrium; Pyridines; Rabbits; Receptors, Angiotensin; Tetrazoles; Zona Glomerulosa | 1993 |
In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Topics: Administration, Oral; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Decerebrate State; Dogs; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Species Specificity; Tetrazoles; Vasoconstrictor Agents | 1995 |
Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Coronary Disease; Coronary Vessels; Disease Models, Animal; Imidazoles; Rats; Recurrence; Sulfonamides; Swine; Tetrazoles | 1996 |
Diphenylpropionic acids as new AT1 selective angiotensin II antagonists.
Topics: Administration, Oral; Adrenal Glands; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Diet, Sodium-Restricted; Furosemide; Imidazoles; In Vitro Techniques; Indicators and Reagents; Kinetics; Liver; Losartan; Male; Models, Molecular; Molecular Structure; Muscle, Smooth, Vascular; Phenylpropionates; Rabbits; Rats; Stereoisomerism; Structure-Activity Relationship; Tetrazoles | 1996 |
Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelium, Vascular; Graft Occlusion, Vascular; Hyperplasia; Imidazoles; Jugular Veins; Microscopy, Electron, Scanning; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Receptors, Angiotensin; Tetrazoles; Tunica Intima | 1996 |
Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cell Division; Cilazapril; Gene Expression Regulation; Hypertension, Renovascular; Imidazoles; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Receptors, Angiotensin; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1996 |
Role of endogenous angiotensin II in renal hemodynamic and excretory responses to L-arginine infusion.
Topics: Anesthesia; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine; Diuresis; Dose-Response Relationship, Drug; Imidazoles; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles; Urination; Urodynamics | 1996 |
What can angiotensin antagonists do that converting-enzyme inhibition can't: the case of post-angioplastic restenosis.
Topics: Angioplasty, Balloon; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Carotid Stenosis; Imidazoles; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Tetrazoles | 1996 |
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cytokines; Enalapril; Fibrin; Fibrinolysin; Fibrosis; Gene Expression Regulation, Enzymologic; Growth Substances; Imidazoles; In Situ Hybridization; Kidney; Male; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Tetrazoles; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 1997 |
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chronic Disease; Extracellular Matrix Proteins; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Imidazoles; Kidney; Lisinopril; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Tetrazoles; Transforming Growth Factor beta | 1997 |
Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Cardiac Output, Low; Hemodynamics; Imidazoles; Male; Rabbits; Sympathetic Nervous System; Tetrazoles | 1997 |
Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diastole; Disease Models, Animal; Dogs; Enalaprilat; Hypertension, Renal; Hypertrophy, Left Ventricular; Imidazoles; Receptors, Angiotensin; Tetrazoles; Ventricular Function, Left | 1997 |
Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutations.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Humans; Imidazoles; Ligands; Mutation; Rats; Receptors, Angiotensin; Tetrazoles | 1997 |
Improved activity of a new angiotensin receptor antagonist by an injectable spray-dried polymer microsphere preparation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Calorimetry, Differential Scanning; Dose-Response Relationship, Drug; Imidazoles; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Microspheres; Polymers; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles | 1997 |
Angiotensin II receptor blockade in Syrian hamster (T0-2) cardiomyopathy does not affect microscopic cardiac material properties: implications for mechanisms of tissue remodeling.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomyopathy, Hypertrophic; Collagen; Cricetinae; Echocardiography; Heart; Imidazoles; Male; Mesocricetus; Myocardium; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 1997 |
AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
Topics: Aging; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Electric Stimulation; Heart; Hypertension; Imidazoles; Kidney; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1997 |
Load-sensitive diastolic relaxation in hypertrophied left ventricles.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Diastole; Dogs; Enalaprilat; Hemodynamics; Hypertension, Renal; Hypertrophy, Left Ventricular; Imidazoles; Tetrazoles | 1998 |
Effect of the novel angiotensin II type 1 receptor antagonist L-158,809 on acute infarct expansion and acute anterior myocardial infarction in the dog.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Disease Models, Animal; Dogs; Echocardiography; Imidazoles; Myocardial Infarction; Random Allocation; Tetrazoles; Ventricular Function, Left | 1998 |
Differential development of umbilical and systemic arteries. I. ANG II receptor subtype expression.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cell Membrane; Dose-Response Relationship, Drug; Femoral Artery; Heart Rate; Imidazoles; Muscle, Smooth, Vascular; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Sheep; Tetrazoles; Umbilical Arteries | 1998 |
Renal AT1 receptor: autoradiographic localization and quantification in rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Autoradiography; Binding, Competitive; Dose-Response Relationship, Drug; Hypertension; Imidazoles; Kidney; Kidney Cortex; Male; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 1998 |
Effects of angiotensin II on sexual function, blood pressure, and fluid intake are differentially affected by AT-1 receptor blockade.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Copulation; Drinking Behavior; Imidazoles; Injections, Intraventricular; Male; Motor Activity; Penile Erection; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Time Factors | 1998 |
Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalaprilat; Female; Heart Failure; Hemodynamics; Imidazoles; Male; Swine; Tetrazoles | 1998 |
Renal c-fos expression induced by angiotensin II is enhanced in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Gene Expression Regulation; Genes, fos; Heart Rate; Imidazoles; Kidney; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles | 1998 |
Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Binding, Competitive; Blood Pressure; Decerebrate State; Diastole; Dose-Response Relationship, Drug; Heart Rate; Imidazoles; In Vitro Techniques; Losartan; Male; Muscle Contraction; Pyridines; Rabbits; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sensitivity and Specificity; Tetrazoles | 1999 |
TGF-beta 1 production in radiation nephropathy: role of angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Female; Imidazoles; Kidney Diseases; Kidney Glomerulus; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Tetrazoles; Transforming Growth Factor beta | 1999 |
Functional role of angiotensin II type 1 and 2 receptors in regulation of uterine blood flow in nonpregnant sheep.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Female; Imidazoles; Injections, Intra-Arterial; Injections, Intravenous; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Regional Blood Flow; Sheep; Tetrazoles; Uterus; Vasoconstriction; Vasoconstrictor Agents | 2000 |
Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Echocardiography; Enalapril; Female; Heart Failure; Hypertension, Renal; Imidazoles; Muscle Fibers, Skeletal; Myocardium; Organ Size; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Tetrazoles; Ventricular Remodeling | 2000 |
Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiac Output; Chronic Disease; Echocardiography; Female; Heart; Heart Failure; Imidazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Organ Size; Ramipril; Stroke Volume; Tetrazoles; Ventricular Remodeling | 2000 |
Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitro.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Area Under Curve; Cell Line; Deoxyglucose; Dose-Response Relationship, Drug; Fructose; Glucose Tolerance Test; Imidazoles; Insulin; Insulin Antagonists; Insulin Resistance; Male; Muscles; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Triglycerides | 2000 |
Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dogs; Hyperplasia; Imidazoles; In Vitro Techniques; Placebos; Receptors, Angiotensin; Tetrazoles; Tunica Intima; Veins | 2000 |
Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Cells, Cultured; DNA; Drug Synergism; Gene Expression Regulation; Imidazoles; Luciferases; Myocardium; Phenylephrine; Potassium Channels; Potassium Channels, Voltage-Gated; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Recombinant Fusion Proteins; RNA, Messenger; Shal Potassium Channels; Tetrazoles; Time Factors; Transcription, Genetic | 2001 |
Induction of heme oxygenase 1 in radiation nephropathy: role of angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Induction; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Imidazoles; Kidney; Kidney Diseases; Rats; Tetrazoles; Transforming Growth Factor beta | 2001 |
Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Cells, Cultured; Down-Regulation; Imidazoles; Male; Muscle, Smooth, Vascular; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Regression Analysis; Tetrazoles; Type C Phospholipases | 2001 |
Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; DNA Primers; Glomerulonephritis; Imidazoles; In Situ Hybridization; Kidney Glomerulus; Lisinopril; Male; Membrane Proteins; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles | 2001 |
Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity.
Topics: Amphotericin B; Angiotensin II; Animals; Antifungal Agents; Arginine; Candida albicans; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Endothelins; Glomerular Filtration Rate; Imidazoles; In Vitro Techniques; Injections, Intravenous; Kidney Diseases; Liposomes; Male; Nitric Oxide; Nitroso Compounds; Oligopeptides; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 2001 |
Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Cell Division; Dose-Response Relationship, Drug; Humans; Imidazoles; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Brain; Corticosterone; Drug Synergism; Imidazoles; Injections, Intravenous; Injections, Intraventricular; Losartan; Male; Microinjections; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values; Tetrazoles | 2001 |
Apoptosis is not increased in myocardium overexpressing type 2 angiotensin II receptor in transgenic mice.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Blood Pressure; Body Weight; Heart Rate; Imidazoles; Male; Mice; Mice, Transgenic; Myocardium; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasoconstrictor Agents | 2001 |
Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Chronic Disease; Collagen; Dose-Response Relationship, Drug; Fibroblasts; GTP-Binding Proteins; Heart; Heart Failure; Heart Septum; Heart Ventricles; Hemodynamics; Imidazoles; Indoles; Lung; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2001 |
Temporal regression of myocyte hypertrophy in hypertensive, heart failure-prone rats treated with an AT1-receptor antagonist.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Female; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Time Factors | 2002 |
Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II.
Topics: Adenocarcinoma; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Apoptosis; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Imidazoles; Losartan; Lung Neoplasms; Pulmonary Alveoli; Pulmonary Fibrosis; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Respiratory Mucosa; Tetrazoles; Tumor Cells, Cultured; Vasoconstrictor Agents | 2002 |
Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles.
Topics: Afferent Pathways; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Male; Norepinephrine; Peptide Fragments; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2002 |
Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Autoradiography; Blood Pressure; Body Weight; Captopril; Drinking; Enzyme Inhibitors; Female; Glomerulonephritis; Glomerulonephritis, Membranous; Imidazoles; Kidney; Kidney Failure, Chronic; Microscopy, Fluorescence; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Tetrazoles | 2002 |
L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibrinolytic Agents; Humans; Imidazoles; Peptide Fragments; Plasminogen Activator Inhibitor 1; Tetrazoles; Tissue Plasminogen Activator; Umbilical Veins | 2002 |
Cardiovascular effects of L-158,809, a new angiotensin type 1 receptor antagonist, assessed using the halothane-anesthetized in vivo canine model.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cardiovascular System; Dogs; Dose-Response Relationship, Drug; Halothane; Imidazoles; Models, Animal; Receptors, Angiotensin; Tetrazoles | 2002 |
Chronic angiotensin II inhibition increases levels of calcitonin gene-related peptide mRNA of the dorsal root ganglia in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Calcitonin Gene-Related Peptide; Ganglia, Spinal; Gene Expression; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Tetrazoles; Thiazepines | 2003 |
Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Humans; Imidazoles; Kidney Glomerulus; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Vascular Endothelial Growth Factor A | 2004 |
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Glucose; Imidazoles; Kidney; Kidney Glomerulus; Male; Mice; Rats; Streptozocin; Tetrazoles; Tumor Suppressor Proteins | 2005 |
Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT1 and AT2 receptors.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Calcium; Calcium Signaling; Cell Nucleus; Chickens; Cytosol; Dose-Response Relationship, Drug; Heart Ventricles; Imidazoles; Indoles; Maleimides; Microscopy, Confocal; Myocytes, Cardiac; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Ventricular Function | 2005 |
Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.
Topics: Actinium; Alpha Particles; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Female; Imidazoles; Kidney; Kidney Tubules; Mice; Mice, Inbred BALB C; Mineralocorticoid Receptor Antagonists; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Spironolactone; Tetrazoles | 2006 |
Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Carotid Body; Chemoreceptor Cells; Heart Failure; Hypoxia; Imidazoles; Immunohistochemistry; Kidney; Male; Models, Animal; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Stimulation, Chemical; Sympathetic Nervous System; Tetrazoles | 2006 |
Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carotid Body; Cell Hypoxia; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure; Imidazoles; Male; Membrane Potentials; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Rabbits; Tetrazoles | 2006 |
Sex differences in the renal changes elicited by angiotensin II blockade during the nephrogenic period.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Blood Pressure; Female; Glomerular Filtration Rate; Imidazoles; Kidney; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Sex Characteristics; Tetrazoles | 2007 |
Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats.
Topics: Aging; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Imidazoles; Insulin; Kidney; Leptin; Male; Metabolic Syndrome; Metabolism; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles | 2007 |
Role of the angiotensin II type-2 receptor in radiation nephropathy.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cell Line; Humans; Imidazoles; Kidney Diseases; Male; Mice; Pyridines; Radiation Injuries, Experimental; Rats; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors | 2007 |
A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Guanine Nucleotide Dissociation Inhibitors; Hypertension; Imidazoles; Male; Muscle, Smooth, Vascular; Proteomics; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; rho-Specific Guanine Nucleotide Dissociation Inhibitors; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetrazoles; Up-Regulation; Vasoconstrictor Agents | 2008 |
Role of angiotensin II in endothelial dysfunction induced by lipopolysaccharide in mice.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Endotoxemia; Imidazoles; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Nitroprusside; Oxidative Stress; Renin-Angiotensin System; Superoxides; Tetrazoles; Vasodilation; Vasodilator Agents | 2007 |
Angiotensin II type 1 receptor antagonist improves the prognosis in rats displaying liver cirrhosis induced by a choline-deficient diet.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Choline; Disease Models, Animal; Imidazoles; Lipid Peroxidation; Liver Cirrhosis; Male; Pyridines; Rats; Rats, Inbred F344; Tetrazoles; Vasoconstrictor Agents | 2008 |
Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats.
Topics: Angiotensin II; Animals; Blood Pressure; Dietary Carbohydrates; Endothelin-1; Fructose; Glucose Tolerance Test; Hypertension; Imidazoles; Immunohistochemistry; Insulin Resistance; Male; Rats; Rats, Wistar; Tetrazoles | 2009 |
Pregnancy decreases GABAergic inhibition of the hypothalamic paraventricular nucleus.
Topics: Action Potentials; Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Bicuculline; Blood Pressure; Drug Interactions; Excitatory Amino Acid Antagonists; Female; GABA Antagonists; gamma-Aminobutyric Acid; Heart Rate; Imidazoles; Kynurenic Acid; Microinjections; Neural Inhibition; Neurons; Paraventricular Hypothalamic Nucleus; Pregnancy; Rats; Rats, Sprague-Dawley; Spectrum Analysis; Sympathetic Nervous System; Tetrazoles | 2009 |